Biometrics

CDISC Conversion

Comprehensive CDISC Mapping and Submission Solutions

Our programmers are actively involved with CDISC initiatives and working groups giving them access to the latest standards. We have a proven track record of implementing complex CDISC mappings for many clients across pharma, biotech, academia and medical devices.
As your partner, we'll leverage our indication-specific knowledge to guide you through the full data mapping process, including:
  • Twenty-plus years of Data Mapping & Standardisation
  • Experts in CDASH, SDTM & ADaM
  • Highly experienced programming team with statistical knowledge and expertise to increase efficiency and transparency

Expert CDISC Solutions from Raw Data to Submission

Standardizing data into CDISC format is a difficult and time-consuming task requiring expert skills and specialist experience to ensure your study meets all the requirements for submission.

Due to updated rulings from the FDA/PMDA, there is now, more requirement than ever to submit data in CDISC format. For the FDA, any study that started on or after December 2016 requires CDISC standardized data. Similarly, a newer ruling for the PMDA has also come into effect for submissions after April 1st 2020.

Our dedicated team of CDISC specialists with combined experience in SDTM, ADaM and associated documentation so no need for separate teams for standardization or analysis. They work across all CDISC standards and have supported many clients with submission efforts to regulatory authorities.

Why choose Alira Health?

The CROS NT and Alira Health biometrics team has provided expert statistical guidance for over 500 projects, including regulatory communication and submissions, study-based data management, biostatistics, and statistical programming. You will benefit from our:

  • Exceptional customer service and site relations
  • In-depth expertise across the entire clinical trial process
  • Flexible and tailored service delivered by multidisciplinary and global teams
  • Frequent, transparent, and professional communication
  • Guarantee we will lead your study efficiently, safely, and successfully

Related News

Clinical Digital Health MedTech Pharma
News November 16, 2021
Alira Health Further Expands its Digital Healthcare Platform with the Acquisition of Patchai
We acquired Patchai, a digital health technology company headquartered in Italy. Patchai offers intelligent digital health solutions that engage and empower patients in clinical research(...)
Clinical Digital Health MedTech Pharma
News October 28, 2021
Alira Health Acquires BEPATIENT, A Step Forward in Humanizing Healthcare
We acquired BEPATIENT, a European healthcare technology company. BEPATIENT offers ‘real life’ digital patient data capture solutions for large pharmaceutical manufacturers, medical(...)
Clinical
Events October 22, 2021
Event: OCT Nordics 2021
Meet us at OCT Nordics October 26- 27, 2021.
Clinical
Events October 22, 2021
Event: OCT New England
Meet us at Outsourcing in Clinical Trials New England.
Clinical
Publications October 7, 2021
Tips for Successful Sponsor and CRO Collaboration
The relationship between Sponsor and CRO is a critical aspect of an effective and timely clinical trial; when the relationship is transparent and smooth, the benefit is seen by all parties.
Clinical
News June 8, 2021
Alira Health Expands Its Global Clinical and Data Capabilities Through the Acquisition of CROS NT
We have acquired CROS NT, a data-driven Contract Research Organization (CRO) headquartered in Italy with offices across Europe and the United States. CROS NT provides high quality,(...)
Clinical
Multimedia June 4, 2021
Managing Relationships Between CROs and Clinical Trial Sites
Join us in this special episode of Alira Health’s Transformation Talks with a full cast of Alira Health experts.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.